$DYAI Income Statement | Understand Stock

$DYAI

$0.39 +$0.00 (0.31%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Grant revenue
Research and Development
Grant
License
Total grant revenue
Costs and expenses:
Provision for contract losses
Costs of research and development revenue
Costs of grant revenue
Research and development
General and administrative
Foreign currency exchange loss
Total costs and expenses

Loss from operations
Gain from the sale of investments in BDI
Unrealized gain from investment in Alphazyme
Interest income
Other income (expense):
Interest income
Gain on sale of Alphazyme
Other income
Interest expense
Nonrelated Party
Related Party
Total other income (expense), net
Loss before income taxes
Provision for income taxes

Net loss
Basic and diluted net loss per common share (in dollars per share)
Basic net loss per common share
Diluted net loss per common share
Basic weighted-average common shares outstanding
Diluted weighted-average common shares outstanding

Comments